Halmova K, Holly D, Stanko P
Bratisl Lek Listy. 2017;118(11):710-713. doi: 10.4149/BLL_2017_134.
The aim of the study was to prove the causality between the craniocervical dysfunction and myofascial pain in the head and neck and to demonstrate the clinical value and usefulness of physiotherapy as one of the therapeutic options for myofascial pain.
The group of patients diagnosed with myofascial dysfunctional pain syndrome contained 98 patients out of which 79 patients (81 %) were females and 19 patients (19 %) were males. The majority of the patients were aged between 26 and 35 years; the total age range was 14-77 years with the average of 38 years. Observed patients were subdivided into three groups. Standard therapeutic methods aimed at the temporomandibular joint were provided to the patients of the first group. The second group of the patients received therapy aimed at cervical muscles only. Complex rehabilitation was applied in the third group of patients. The most frequent method used in the evaluation of chronic musculoskeletal pain in clinical studies is the visual analogue scale (VAS).
According to our results, all three groups of patients saw an improvement in pain perception, but the overall subjective remission of painful sensations in the third group took place in as many as 88 % of patients. In this group, there was a significant decrease in the tenderness of trigger points in the trapezius and sternocleidomastoid muscles.
It was proved that a combination of simple relaxing and stretching exercises of cervical muscles with a standard method used in the therapy of masticatory muscles is significantly more efficient (Fig. 5, Ref. 18).
本研究旨在证明颅颈功能障碍与头颈部肌筋膜疼痛之间的因果关系,并证明物理治疗作为肌筋膜疼痛治疗选择之一的临床价值和实用性。
诊断为肌筋膜功能障碍性疼痛综合征的患者组有98例,其中79例(81%)为女性,19例(19%)为男性。大多数患者年龄在26至35岁之间;总年龄范围为14 - 77岁,平均年龄为38岁。观察的患者被分为三组。第一组患者接受针对颞下颌关节的标准治疗方法。第二组患者仅接受针对颈部肌肉的治疗。第三组患者采用综合康复治疗。临床研究中评估慢性肌肉骨骼疼痛最常用的方法是视觉模拟量表(VAS)。
根据我们的结果,所有三组患者的疼痛感知都有改善,但第三组中多达88%的患者疼痛感觉总体主观缓解。在该组中,斜方肌和胸锁乳突肌触发点的压痛明显减轻。
已证明颈部肌肉简单的放松和伸展运动与咀嚼肌治疗中使用的标准方法相结合显著更有效(图5,参考文献18)。